Abstract: Epstein-Barr virus is a DNA virus infecting human beings and could affect 90% of human population. It is crucial to take in account that in Latin America, unlike what happens in developed countries, the exposure to the virus is very early and therefore people have a much longer interaction with the virus. The virus is related to many diseases, mainly the oncological ones, and when the onset is in cutaneous tissue, it can present many clinical variants, as well acute as chronic ones. Among the acute ones are infectious mononucleosis rash and Lipschutz ulcers; the chronic presentations are hypersensivity to mosquito bites, hydroa vacciniforme, hydroa vacciniforme-like lymphoma, its atypical variants and finally nasal and extra-nasal NK/Tcell lymphoma. Although they are not frequent conditions, it is crucial for the dermatologist to know them in order to achieve a correct diagnosis.
INTRODUCTION

Epstein-Barr virus (EBV) is a DNA virus that infects human
beings and is related to its oncogenic capacity in different kinds of human neoplasia and, when it affects the cutaneous tissue it origins various clinical processes, which are not frequent but whose diagnose is difficult. On the current article, we present a detailed review of EBV history, the characteristics of its structure and its way of interrelationship with the host, its patterns of activity, latency and reactivation, and the pathological clinical pictures it produces in the skin.
EBV AND SKIN
EBV is a DNA virus classified on Herpesviridae family, Gammaherpesvirinae subfamily, Lymphocrytovirus genus (herpes virus gamma 1) and Human Herpesvirus type 4 species, which infects human beings and is, until now, the first human virus directly involved on lymphoid and epithelial tumors oncogenesis. 1 Up to the present, two kinds of EBV varieties were described: 1 and 2, which are distinguished by the genes codifying some of the nuclear proteins.
EBV was discovered in 1964, through electronic microscopy of Burkitt lymphoma cultivated cells by Michael Epstein, Ivonne
Barr e Bert Achong. It became the first identified human tumoural virus. 2, 3 In 1968, EBV showed to be the etiological agent of heterophile-positive infectious mononucleosis (IM). In 1970, EBV DNA was detected on patient's tissues having nasopharyngeal carcinoma. In the 1980s, the association between EBV and non-Hodgkin lymphoma and oral hairy leukoplakia in patients having acquired immunodeficiency syndrome (AIDS) was discovered. Since then, EBV DNA has been found in tissues of other cancers, including T lymphomas and Hodgkin disease. 2 As the technology progress, EBV became the first human virus to have its genome completely sequenced. Human beings are the only known hosts of EBV, nevertheless this virus is genetically related to the viruses found on the oropharynx and B cells of non-human primates of the Old World, suggesting that probably it has evolved from a non-human primates virus . 
VIRAL STRUCTURE AND FEATURES OF EBV
EBV contains a 172kb linear DNA genome whose structure has been appropriately studied and determined. Since the infection of the host cell, the linear genome virus is transformed on a DNA circular episomal structure. EBV genome is composed by a single sequence of long and short domains and repetitive sections referred as repetitive internal parts 1 and repetitive terminal sections. The heterogeneity of the repetitive terminal sections on episomal DNA were explored in order to determine the clonal events of the infection, as well as the number of episomal repetitive terminals remaining unaltered during the replication of the virus on latent phase in an infected cell.
EBV genome is included inside a nucleocapsid, which, in turn, is surrounded by a viral membrane. EBV shows a remarkable tropism for B cells. Before the virus enters in B cells, the glycoprotein of viral envelope, gp350, unites to the viral receptor, CD21 molecule (receptor of C3d complement) on B cells surface. 2 An EBV recombinant virus lacking of gp350 can transform B cells with less efficiency, consequently the C3d complement receptor probably is not the only portal through which the virus could enter in B cells, nevertheless it is clearly the most predominant; the antibodies against gp350
blocking the viral link neutralize B cells infection, and soluble forms of C3d or gp350 can do the same. 4, 5 At least, other 3 union mechanisms proposed do not include neither gp350 nor CD21 (Chart 1).
The first one was a demonstration that the viruses treated with immunoglobulin A specific for gp350 united easily to the polymeric receptor of immunoglobulin A. The second union mechanism was the demonstration that, in the absence of CD21, a complex of two additional glycoproteins, gH e gL, can serve as epithelial ligands.
EBV stemmed from a B cell can unite appropriately to an epithelial cell CD21 negative, but the recombinant viruses lacking gHgL loose this ability. 4 A soluble form of gHgL made on a baculovirus can unite specifically to epithelial cells but not to B cells, and their union can diminish by means a monoclonal antibody specific for gHgL complex. The same antibody can also diminish the viral link. These observations have been interpreted as the existence of a receptor on the epithelial cell for gHgL, useful on the viral link that has not been discovered yet. The studies demonstrated the prevalence of EBV infection on virtually the whole human population, affecting more than 90% of the individuals during the two first decades of life over the world. In the developing countries, the primary EBV infections take place during the first years of life and use to be asymptomatic. In developed countries, there is a tendency to late primary nfection, with a higher proportion of infections found in adolescents and young adults, and they manifest clinically as autolimited infections referred as IM.
EBV INFECTION AND THE HOST RESPONSE
The main virus way of entry is the upper respiratory tract.
The infected B cells are frequently identified on the normal nasopharynx mucosa and the tonsils, since then as part of the normal migration and lymphocyte circulation, these EBV infected B cells spread in the lymph nodes, the peripheral blood and other muco- 
Lytic phase
The lytic phase is that observed in the primary infection. In Studies using mutants lacking Zta or Rta showed that both proteins are necessary to the virus production. 
Latency type II program
Finally, the latency program type II was originally identified in nasopharyngeal carcinoma and, subsequently, found in cases of Hodgkin lymphoma associated to EBV. 7, 8 This kind of latency was divided in two subtypes, type II A and type II B. Although both latencies share many common findings, they are distinguished by the lack of expression of two proteins quite necessary for cellular transformation: EBNA 2 is absent in latency type II A and LPM 1 is absent in latency type II B.
Latency type II A
In this kind of latency pattern, the expression of EBV gene is limited to EBNA 1, LPM 1 and LPM 2. It was initially identified in nasopharyngeal carcinoma and NK-cell lymphomas.
Latency type II B
This kind of latency program is characterized by the expression of all EBNA proteins and the lack of LPM 1. This pattern was primarily detected in patients with chronic lymphocytic leukemia type B (Chart 3).
DIAGNOSTIC METHODS Southern blot technique is useful for EBV detection, espe-
cially for the investigation of viral clonality. Nevertheless, the sensibility is lower when it is compared to the polymerase chain reaction (PCR). Differently to Southern blot, PCR can be used in paraffin-embedded tissues, besides it allows the viral subtypification and the LMP-1 delection evaluation. However, neither Southern blot nor PCR allow the identification of which cells are infected by the virus. 6 Moreover, during the latent infection, the EBERs are highly transcribed and the nucleus often contains more than 10 copies of the virus. The EBER detection by in situ fluorescent hybridization showed to be a reliable method and was recommended as the best method for detecting latent EBV in biopsies. Some inconvenient are the positivity of non-tumoral lymphocytes carrying latent EBV and false positive through some contaminants as mucin, yeasts and plant material. 6 There are commercial antibodies against LMP-1 and EBNAs, nevertheless they show to have low sensibility. For example, LMP-1 expression rate detectable by immunohistochemistry varies from 50 to 80%. On the other hand, LMP-1 can also be detected by hybridization of paraffin-embedded tissues with LMP-1-SERS method, which showed to be superior than conventional immunohistochemical staining for LMP-1, and similar to in situ hybridization for EBER (Chart 4).
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EBV AND ITS SKIN MANIFESTATIONS EBV is a virus very difficult to detect by auxiliary studies
and, therefore, it is very complicate to determinate its participation on the pathogenesis of the cutaneous diseases. On the other hand, the occurrence of these diseases is also not very common in the cutaneous pathology but, due to its unusual presentation and possible complications, it is important to recognize them.
The forms of presentation can be divided into two: the acute forms and the chronic ones. In adolescents and young adults, EBV infections often result in an IM. They get the infection through transmission of oropharingeal secretions and, after incubation period (30-50 days), the disease is expressed clinically in more than 70% of exposed adolescents. 9 It is an autolimited lymphoproliferative disease, with several days of fever (2 -3 weeks), pharyngitis associated with exudate (30% cases) and cervical adenopathies. During prodomal phase, the patient presents weakness, anorexia, fatigue, headache and fever.
ACUTE FORMS
INFECTIOUS MONONUCLEOSIS
The presence of splenomegaly is variable, detectable on the phys- They are painful ulcers on external genitals, generally present in female adolescents with with a mean age of 14.5 years old.
They affect about 10 to 30% of female adolescents. Usually it affects the posterior commissure (frenulum) of labia minora but can extend to the labia majora, the perineum and the lower part of the vagina, and it is characteristic the simmetric bilateral involvement, described as mirror image. 10 Other signs can be present like swelling of lips and inguinal adenopathy. The distant lymphadenopathy is frequent. 3, 10 Severe pain and dysuria are constantly reported. 10 In approximately 70% of the cases, it is reported an oral impairment like thrush. Lipschutz ulcers usually appear in single episodes, differently from those caused by herpes simplex virus. 3 The healing of the acute lesion happens from 2 to 6 weeks after and does not leave scars. 10 Laboratory studies, as well as culture tests, 
GIANOTTI-CROSTI SYNDROME (GCS)
GCS, syndrome or papular acrodermatitis of childhood is an autolimited eruption of acral location and acute course with generalized lymphadenopathy. The syndrome is characterized by a papular and monomorphic eruption, with symmetrical edematous papules tending to be asymptomatic. It is located in cheeks, back of the hands, buttocks and extensor aspects of arms and thighs in children from 2 to 6 years old. 13 It is considered a non-specific cutaneous response to many infectious agents, specially viruses, the EBV is one of the most frequently associated. GCS can be the manifestation of an EBV primary infection or the result of a endogeneous viral reactivation. Other ethiological agents include hepatitis B virus, cytomegalovirus, adenovirus, coxsackievirus, parainfluenza virus, poxvirus, parvovirus B19 e HHV-6.
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The association of EBV primary infection and GCS can be diagnosed only by serology. From the histological point of view, the findings are unspecific and include focal parakeratosis, mild spongiosis, superficial perivascular infiltrate, red blood cell extravasation and edema of the papillary dermis. This last was emphasized as being prominent in GCS cases associated to EBV and is due to the high number of cytotoxic T cells, which compose the inflammatory infiltrate. 13 There is still no evidence of viral antigens or particles with the aid of in situ hybridization or immunohistochemistry.
CHRONIC ACTIVE INFECTION BY EBV
A group of patients presents recurrent cases of IM for more than 6 months. This condition is known in the literature as chronic active EBV infection (CAEBV) and is considered a lymphoproliferative disorder that occurs mainly in children. 6 By definition, this dis- Finally, it is concluded that HMB occurs in close association with NK cells disease, where monoclonal EBV infects the cells. For this reason, nowadays it is known as "HMB-EBV-NK disease". 15 The HBV is a disease generally associated to EBV chronic infection and, in some cases, can precede this one. It is a cutaneous disorder characterized by an intense cutaneous local reaction presented as erythema, blisters, ulcers and scar tissue formation, followed by systemic symptoms as fever, lymphadenopathy, hepatic dysfunction and hemophagocyt syndrome after mosquito bite. The target cells of latent EBV infection in HMB are NK cells and T NK cells. 16 The mechanism of this process would be due to the stimulation by the mosquito saliva to infected cells.
Clinically, three stages are observed: initially there is an overreaction to mosquito bite characterized by erythema, blisters, ulcers and scar tissue formation; later the patients develop many episodes of systemic symptoms as fever, lymphadenopathy and hepatic dysfunction. These patients have potential risks of leukemia or lymphomas and some of them have already the mentioned diagnoses, including on the first episode of HMB. Finally, one of the more severe complications is hemaphagocytic syndrome, which is produced on the final stages. 15 The majority of patients has under 20 years old, in average 6.7 years old and it is important to distinguish it from allergic reaction to mosquito bite taking in account the severity of cutaneous lesions and the associated systemic symptoms 
HYDROA VACCINIFORME-TYPE T-CELL LYMPHOMA (HVTL)
On the last 20 years in Mexico, Bolivia and Peru, many cases of patients having cutaneous lesions similar to HV were published.
At first, they were described as atypical or severe HV, as they later evolved with systemic complications. These cases showed a slow and progressive evolution and finally a complication with malignant lymphoma. Overtime, this entity was identified as a HVTL.
HVTL occurs predominantly in children and adolescents, Figure 5A ). The lymphoid infiltrate can be found on the deep dermis and hypodermis, for this reason the biopsy must be deep to reach the correct diagnosis ( Figure 5B ).
EBV-ASSOCIATED NK/T-CELL LYMPHOMAS NK/T-cell lymphoma is much more frequent in Asia and
Latin America (2.6 to 7%) than in United States or Europe (1.5%). 
